Inverse Salt Sensitivity of Blood Pressure: Mechanisms and Potential Relevance for Prevention of Cardiovascular Disease.

Robin A Felder, John J Gildea, Peng Xu, Wei Yue, Ines Armando, Robert M Carey, Pedro A Jose

Journal: Current hypertension reports 2022;24(9):361-374

PMID: 35708819

Abstract

PURPOSE OF REVIEW

To review the etiology of inverse salt sensitivity of blood pressure (BP).

RECENT FINDINGS

Both high and low sodium (Na) intake can be associated with increased BP and cardiovascular morbidity and mortality. However, little is known regarding the mechanisms involved in the increase in BP in response to low Na intake, a condition termed inverse salt sensitivity of BP, which affects approximately 15% of the adult population. The renal proximal tubule is important in regulating up to 70% of renal Na transport. The renin-angiotensin and renal dopaminergic systems play both synergistic and opposing roles in the regulation of Na transport in this nephron segment. Clinical studies have demonstrated that individuals express a "personal salt index" (PSI) that marks whether they are salt-resistant, salt-sensitive, or inverse salt-sensitive. Inverse salt sensitivity results in part from genetic polymorphisms in various Na regulatory genes leading to a decrease in natriuretic activity and an increase in renal tubular Na reabsorption leading to an increase in BP. This article reviews the potential mechanisms of a new pathophysiologic entity, inverse salt sensitivity of BP, which affects approximately 15% of the general adult population.

© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Address: Department of Pathology, The University of Virginia, Charlottesville, VA, USA. [email protected].; Department of Pathology, The University of Virginia, Charlottesville, VA, USA.; Department of Medicine and Department of Physiology/Pharmacology, Division of Renal Diseases & Hypertension, The George Washington University School of Medicine and Health Sciences, Washington, DC, USA.; Department of Medicine, Division of Endocrinology and Metabolism, The University of Virginia, Charlottesville, VA, USA.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.